Amphotericin B liposome (Gilead)

两性霉素B脂质体 (吉利德)

Report date: 2026/03/04 20:01:44

Base Information

Drug NameAmphotericin B liposome (Gilead)
Drug Alias NameAmfotericina B liposomeAnfotericina B liposomeAmphotericinum B liposomeAmBisome安必速 +[7] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of ActionCell membrane permeability enhancersErgosterol binders
TargetsErgosterol
Therapy Area/IndicationsFebrile NeutropeniaAcquired Immunodeficiency SyndromeLeishmaniasis, Visceral +[12] 
Global Approved IndicationsFebrile NeutropeniaLeishmaniasis, VisceralLeishmaniasis +[7] 
Approved Indications in ChinaMycoses
Original Approved Country/TerritoryIreland
Original Approved Date1990/12/13
Country/TerritoryUnited StatesItalyIreland +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGilead Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesInstituto Gonçalo MonizFederal University Of Health Sciences Of Porto AlegreGilead Sciences Inc +[7] 
Inactive CompaniesN/A
Active IndicationsFebrile NeutropeniaAcquired Immunodeficiency SyndromeLeishmaniasis, Visceral +[12] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG